Paul Weisman

937 total citations
50 papers, 642 citations indexed

About

Paul Weisman is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Paul Weisman has authored 50 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 13 papers in Reproductive Medicine. Recurrent topics in Paul Weisman's work include Ovarian cancer diagnosis and treatment (13 papers), Cancer and Skin Lesions (9 papers) and Sarcoma Diagnosis and Treatment (9 papers). Paul Weisman is often cited by papers focused on Ovarian cancer diagnosis and treatment (13 papers), Cancer and Skin Lesions (9 papers) and Sarcoma Diagnosis and Treatment (9 papers). Paul Weisman collaborates with scholars based in United States, Italy and South Korea. Paul Weisman's co-authors include Pamela K. Kreeger, Jin Xu, Eui S. Jung, Woojin Park, Kay J. Park, Manish S. Patankar, Kristyn S. Masters, Lisa Barroilhet, Suzanne M. Ponik and Xinhai Yang and has published in prestigious journals such as Analytical Chemistry, Cancer Research and American Journal Of Pathology.

In The Last Decade

Paul Weisman

45 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Weisman United States 14 199 189 123 96 94 50 642
Edwin Alvarez United States 12 290 1.5× 202 1.1× 74 0.6× 187 1.9× 64 0.7× 31 734
David Loven Israel 16 377 1.9× 220 1.2× 109 0.9× 32 0.3× 160 1.7× 38 844
Zohar Yehoshua United States 24 152 0.8× 450 2.4× 30 0.2× 52 0.5× 75 0.8× 39 2.4k
Paulina Antosik Poland 11 179 0.9× 183 1.0× 114 0.9× 29 0.3× 72 0.8× 45 452
Yi‐Jou Tai Taiwan 11 260 1.3× 133 0.7× 65 0.5× 62 0.6× 42 0.4× 35 561
Mei Shi China 20 313 1.6× 161 0.9× 189 1.5× 32 0.3× 359 3.8× 90 1.1k
Yong‐Man Kim South Korea 10 99 0.5× 246 1.3× 91 0.7× 60 0.6× 94 1.0× 25 577
Erika Márton Austria 14 241 1.2× 326 1.7× 133 1.1× 115 1.2× 94 1.0× 15 716
Kara A. Lombardo United States 16 379 1.9× 253 1.3× 111 0.9× 63 0.7× 404 4.3× 58 929
Yoon Ah Cho South Korea 14 116 0.6× 178 0.9× 107 0.9× 11 0.1× 49 0.5× 36 437

Countries citing papers authored by Paul Weisman

Since Specialization
Citations

This map shows the geographic impact of Paul Weisman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Weisman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Weisman more than expected).

Fields of papers citing papers by Paul Weisman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Weisman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Weisman. The network helps show where Paul Weisman may publish in the future.

Co-authorship network of co-authors of Paul Weisman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Weisman. A scholar is included among the top collaborators of Paul Weisman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Weisman. Paul Weisman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jennings, Lawrence J., Drew Duckett, Borislav A. Alexiev, et al.. (2025). 91 Novel Low-Grade Fibroblastic Neoplasm with Co-Expression of MUC4 and Beta-catenin: Clinicopathologic and Molecular Characterization of Eight Cases. Laboratory Investigation. 105(3). 102314–102314. 1 indexed citations
3.
Accola, Molly A., et al.. (2024). Pilomatrix-like breast carcinoma: A mammary analog of pilomatrix-like high-grade endometrioid carcinoma (PiMHEC). American Journal of Clinical Pathology. 163(3). 388–394. 1 indexed citations
4.
5.
Geye, Heather M., Menggang Yu, Paul Weisman, et al.. (2024). Morphologic Spectrum of HPV-associated Sinonasal Carcinomas. Head and Neck Pathology. 18(1). 67–67. 3 indexed citations
6.
McCarthy, Daniel P., et al.. (2023). A combined, supraclavicular, infraclavicular, transaxillary, and posterior subscapular approaches for en bloc resection of giant myxofibrosarcoma. Surgical Neurology International. 14. 144–144. 1 indexed citations
7.
Weisman, Paul, et al.. (2023). Adenosquamous carcinoma in situ of the anus: a case series. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 482(6). 993–997.
8.
Bennett, Daniel, et al.. (2023). Spatial transcriptomics of a giant pilomatricoma. Journal of Cutaneous Pathology. 50(11). 963–970. 1 indexed citations
9.
Weisman, Paul, et al.. (2023). Fluorescein Mapping in Vulvar Paget Disease. Obstetrics and Gynecology. 141(3). 608–612.
10.
Weisman, Paul, et al.. (2022). HER2-positive/ER-low breast carcinoma shows a response to neoadjuvant chemotherapy similar to that of HER2-positive/ER-negative breast carcinoma. Pathology - Research and Practice. 238. 154087–154087. 2 indexed citations
11.
Taha, Isra, Aisha Khan, Stephanie M. McGregor, et al.. (2021). Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas. Journal of Histochemistry & Cytochemistry. 70(2). 151–168. 9 indexed citations
12.
Hui, Pei, Natália Buza, Ahmed Al‐Niaimi, et al.. (2021). HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma. International Journal of Gynecological Pathology. 41(2). 132–141. 20 indexed citations
13.
Ashley, Charles, Arnaud Da Cruz Paula, Lorenzo Ferrando, et al.. (2021). Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma. Histopathology. 79(2). 176–186. 5 indexed citations
14.
Khan, Aisha, et al.. (2020). Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases. Tissue Engineering Part A. 26(13-14). 747–758. 21 indexed citations
15.
Stanic, Aleksandar K., et al.. (2020). Benign ovarian thecoma with markedly elevated serum inhibin B levels mimicking adult granulosa cell tumor. Gynecologic Oncology Reports. 34. 100658–100658. 1 indexed citations
16.
Patankar, Manish S., et al.. (2018). Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. Cancer Research. 78(13). 3560–3573. 64 indexed citations
17.
Gettle, Lori Mankowski, et al.. (2018). Solitary CNS Metastasis on Initial Presentation of High Grade Serous Carcinoma of the Fallopian Tube. Case Reports in Obstetrics and Gynecology. 2018(1). 6930986–6930986. 2 indexed citations
18.
Rosenbaum, Jason N. & Paul Weisman. (2017). The Evolving Role of Companion Diagnostics for Breast Cancer in an Era of Next-Generation Omics. American Journal Of Pathology. 187(10). 2185–2198. 13 indexed citations
19.
Buehler, Darya & Paul Weisman. (2017). Soft Tissue Tumors of Uncertain Histogenesis. Clinics in Laboratory Medicine. 37(3). 647–671. 3 indexed citations
20.
Weisman, Paul, Charlotte K.Y. Ng, Edi Brogi, et al.. (2016). Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology. Modern Pathology. 29(5). 476–488. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026